Prognostic Importance of HPV Association in Locally Advanced Inoperable Oropharyngeal Cancer (original) (raw)

International Journal of Radiation Oncology*Biology*Physics, 2012

Abstract

Conclusions: MFO-IMPT is clinically feasible for head and neck cancer with low acute toxicity and excellent clinical response. Proton therapy may represent the next step in the technological advancement of radiation therapy for head and neck cancer. Author Disclosure: S.J. Frank: E. Research Grant; NIH/NCI PO1 Proton Therapy. F. Honoraria; Elekta. G. Consultant; MD Anderson Physician Network. H. Travel Expenses; Elekta. J.D. Cox: None. M. Gillin: None. D.I. Rosenthal: None. A.S. Garden: None. K. Ang: None. R. Mohan: E. Research Grant; NIH/NCI PO1 Proton Therapy. M.B. Palmer: E. Research Grant; Philips Medical System. M. Amin: None. X.R. Zhu: None.

Christian Huebbers hasn't uploaded this paper.

Let Christian know you want this paper to be uploaded.

Ask for this paper to be uploaded.